Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2012-10-29 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2012
Regulatory Filings Classification · 100% confidence The document text is very short (297 characters) and announces a 'strategic partnership' between two companies, concluding with the instruction to 'read the full announcement in pdf.' This structure strongly suggests an announcement about a corporate event or agreement rather than the full agreement document itself. Since the event is a strategic partnership (M&A/Alliance related), and it is presented as a brief notice pointing to a full document, it fits best as a general Regulatory Filing (RNS) or potentially a placeholder for a transaction announcement. Given the options, and the lack of specific M&A language (like 'takeover bid' or 'merger proposal' which would point to TAR), RNS is the most appropriate fallback for a general corporate announcement that directs the user elsewhere for details. However, since it is an announcement of a significant business agreement, and RNS is the general regulatory fallback, I will use RNS.
2012-10-29 English
Regulatory Filings 2012
Regulatory Filings Classification · 99% confidence The document text is extremely short (249 characters) and announces the termination of a share buyback program due to a strategic partnership/acquisition. Crucially, it directs the reader to 'Read the full announcement in PDF format.' This structure—a brief notification pointing to a full document—strongly suggests this is an announcement about a corporate action rather than the detailed filing itself. Since the action involves a share buyback termination, the most specific category is 'Transaction in Own Shares' (POS). However, given the brevity and the instruction to read the full announcement elsewhere, it could also be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the core subject is the termination of a share buyback, POS is the most accurate subject matter classification, but the format strongly suggests RPA/RNS. Given the options, and that the text describes a corporate action (termination of buyback), POS is the primary subject. If the text were longer and contained the details, it would be POS. As a short announcement pointing to the full details, RPA is plausible, but POS captures the event type best. I will lean towards POS as the event described is a transaction in own shares, even if this specific text is just the notification.
2012-10-29 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document is a formal announcement dated October 29, 2012, titled "Termination of share buyback program." It details the cessation of a previously initiated share repurchase program (governed by EC Regulation No 2273/2003) due to a new strategic acquisition. It provides specific transaction details (shares purchased, value) and updates the total treasury stock held. This content directly relates to the company's own shares being bought or sold, which aligns precisely with the definition for 'Transaction in Own Shares' (POS). It is not a general financing update (CAP) but a specific report on the execution and termination of a buyback program.
2012-10-29 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document is a formal announcement dated October 29, 2012, titled "Termination of share buyback program." It details the cessation of a previously initiated share repurchase program (governed by EC Regulation No 2273/2003) due to a new strategic acquisition. It provides specific transaction details (shares purchased, value) and updates the total treasury stock held. This content directly relates to the company's own shares being bought or sold, which aligns precisely with the definition for 'Transaction in Own Shares' (POS). It is not a general financing update (CAP) but a specific report on the execution and termination of a buyback program.
2012-10-29 English
M&A Activity 2012
M&A Activity Classification · 99% confidence The document text is very short (348 characters) and is written in Danish. It announces a strategic partnership between Novozymes and Beta Renewables regarding cellulosic biofuels. Crucially, the last line states: 'læs hele meddelsen i pdf format' (read the whole announcement in pdf format). This indicates the document is an announcement about a piece of news, not the detailed report or agreement itself. Since there is no specific category for 'Partnership Announcement' and it is a general regulatory/news announcement that doesn't fit ER, CT, or other specific financial reports, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general announcement mechanism.
2012-10-29 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes initiated a 'share buyback program' and details the amount and period for buying back 'B shares'. This directly relates to the company repurchasing its own stock. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although the text ends with 'Read the full announcement in PDF format,' suggesting it might be an RPA, the core content is a direct announcement of the buyback program itself, making POS the most accurate classification for the subject matter, especially given the short length which implies this is the primary announcement.
2012-10-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.